1-phenyl-8-[[4-(Pyrrolo[1,2-a]quinoxalin-4- yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one: Synthesis, crystal structure and anti-leukemic activity

8Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

1-Phenyl-8-[[4-(pyrrolo[1,2-a]quinoxalin-4-yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan- 4-one has been successfully synthesized via a multi-step pathway starting from 2-nitroaniline. Structure characterization of this original pyrrolo[1,2-a]quinoxaline derivative was achieved by FT- IR,1H-NMR,13C-NMR, X-Ray and HRMS spectral analysis. This title compound shows interesting cytotoxic potential against several human leukemia cell lines (K562, HL60, and U937 cells).

Cite

CITATION STYLE

APA

Guillon, J., Savrimoutou, S., Rubio, S., Moreau, S., Pinaud, N., Marchivie, M., & Desplat, V. (2020). 1-phenyl-8-[[4-(Pyrrolo[1,2-a]quinoxalin-4- yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one: Synthesis, crystal structure and anti-leukemic activity. MolBank, 2020(1). https://doi.org/10.3390/M1113

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free